The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 357:2203-2204 November 22, 2007 Number 21
NextNext

Acute Ischemic Stroke

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by van der Worp, H. B.
-PubMed Citation
To the Editor: In the Clinical Practice article by van der Worp and van Gijn (Aug. 9 issue),1 the question of the age at which a patient could be selected for treatment with intravenous thrombolysis warrants further attention. According to the Safe Implementation of Thrombolysis in Stroke Monitoring Study (SITS-MOST) selection criteria,2 this treatment cannot be delivered to patients older than 80 years of age in routine clinical practice, but it has been shown that early treatment with recombinant tissue plasminogen activator (rt-PA) in carefully selected elderly patients is as safe and efficacious as it is in younger patients.3 A . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.